Article
Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 Oct 2008
Mössner Rainald, Schuhmacher Anna, Schulze-Rauschenbach Svenja, Kühn Kai-Uwe, Rujescu Dan, Rietschel Marcella, Zobel Astrid, Franke Petra, Wölwer Wolfgang, Gaebel Wolfgang, Häfner Heinz, Wagner Michael, Maier Wolfgang
Abstract excerpt
In recent years, evidence has been accumulating indicating a major role of glutamate in the pathogenesis and pathophysiology of schizophrenia. Of particular importance in this regard are the metabotropic glutamate receptors (GRM). Thus, a recently published trial of the amino acid analogue LY2140023, which exerts its effects through the activation of the glutamate receptors GRM3/GRM2, showed an improvement of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
